ZimVie Inc. (NASDAQ:ZIMV) Position Raised by Ancora Advisors LLC

Ancora Advisors LLC increased its position in ZimVie Inc. (NASDAQ:ZIMV - Free Report) by 460.8% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 112,160 shares of the company's stock after purchasing an additional 92,160 shares during the quarter. Ancora Advisors LLC owned 0.41% of ZimVie worth $1,565,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors have also added to or reduced their stakes in ZIMV. Dimensional Fund Advisors LP boosted its position in ZimVie by 9.4% in the 4th quarter. Dimensional Fund Advisors LP now owns 1,244,938 shares of the company's stock valued at $17,367,000 after buying an additional 107,461 shares during the last quarter. American Century Companies Inc. increased its holdings in ZimVie by 23.9% during the 4th quarter. American Century Companies Inc. now owns 628,050 shares of the company's stock worth $8,761,000 after purchasing an additional 121,053 shares during the last quarter. Gamco Investors INC. ET AL raised its position in shares of ZimVie by 15.1% in the 4th quarter. Gamco Investors INC. ET AL now owns 519,112 shares of the company's stock valued at $7,242,000 after purchasing an additional 68,176 shares in the last quarter. Northern Trust Corp boosted its stake in shares of ZimVie by 3.5% during the 4th quarter. Northern Trust Corp now owns 326,252 shares of the company's stock valued at $4,551,000 after buying an additional 10,988 shares during the last quarter. Finally, Russell Investments Group Ltd. increased its stake in shares of ZimVie by 1.7% in the fourth quarter. Russell Investments Group Ltd. now owns 276,443 shares of the company's stock worth $3,856,000 after buying an additional 4,739 shares during the last quarter. 95.63% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several research analysts have weighed in on ZIMV shares. B. Riley assumed coverage on shares of ZimVie in a report on Thursday, April 10th. They set a "buy" rating and a $16.00 price objective for the company. Needham & Company LLC reiterated a "hold" rating on shares of ZimVie in a report on Wednesday, April 9th.

ZimVie Stock Performance

Shares of NASDAQ ZIMV traded up $0.12 during mid-day trading on Wednesday, hitting $8.91. The company had a trading volume of 113,890 shares, compared to its average volume of 219,768. The stock has a market cap of $248.12 million, a price-to-earnings ratio of -0.68 and a beta of 2.16. The firm's 50 day simple moving average is $10.50 and its two-hundred day simple moving average is $12.73. The company has a debt-to-equity ratio of 0.57, a current ratio of 1.94 and a quick ratio of 1.38. ZimVie Inc. has a 12 month low of $8.56 and a 12 month high of $22.40.

ZimVie (NASDAQ:ZIMV - Get Free Report) last posted its earnings results on Wednesday, February 26th. The company reported $0.27 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.25 by $0.02. The firm had revenue of $111.52 million during the quarter, compared to analyst estimates of $113.67 million. ZimVie had a negative net margin of 77.31% and a positive return on equity of 2.90%. As a group, equities research analysts forecast that ZimVie Inc. will post 0.6 earnings per share for the current year.

ZimVie Profile

ZimVie Inc, together with its subsidiaries, develops, manufactures, and markets a portfolio of products and solutions designed to treat various spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It operates through two segments, The Dental Segment and The Spine Segment.